Volume 32, Issue 9 (December 2021)                   Stud Med Sci 2021, 32(9): 674-683 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pashaiasl M, Pashaei-asl R, Paknejad M. THE APPLICATION OF AMNIOTIC FLUID-DERIVED MESENCHYMAL STEM CELL-CONDITIONED MEDIUM IN CANCER TREATMENT. Stud Med Sci. 2021; 32 (9) :674-683
URL: http://umj.umsu.ac.ir/article-1-5682-en.html
Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran , paknejadma@tums.ac.ir
Abstract:   (303 Views)
Currently, chemotherapy and surgery are the main strategies in the clinical treatment of cancer. However, the side effects of chemotherapy drugs on normal tissues affect the quality of a patient’s life. In addition, the resistance of the cancer cells to anticancer drugs limits the therapeutic effects. Therefore, the discovery of new treatments to improve cancer therapy is required. In recent years, many studies have shown the potential inhibitory effects of mesenchymal stem cells in cancer progression. Human amniotic fluid mesenchymal stem cells (hAFMSCs) are the unique type of human mesenchymal stem cells that are suitable for some human diseases. Furthermore, recently there are investigations on the anticancer effects of these types of cells. Conditioned medium of mesenchymal stem cells has more advantages than stem cells, such as being easy to produce, package, freeze, and transport, which can lead to drug production. As a result, the conditioned media of amniotic fluid mesenchymal stem cells can be a beneficial candidate for cancer treatment.
Full-Text [PDF 925 kb]   (70 Downloads)    
Type of Study: Review article | Subject: بیوشیمی

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Studies in Medical Sciences

Designed & Developed by : Yektaweb